1-12 of 12
Jiaoti Huang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting AXL Inhibits the Growth and Metastasis of Prostate Cancer in Bone

Available to Purchase
Chun-Lung Chiu, Dalin Zhang, Hongjuan Zhao, Yi Wei, Alexandra Lapat Polasko, Mikkel Thy Thomsen, Vanessa Yang, Kasie Kexin Yang, Spencer Hauck, Eric E. Peterson, Ru M. Wen, Zhengyuan Qiu, Eva Corey, Yu Rebecca Miao, Erinn B. Rankin, Donna M. Peehl, Jiaoti Huang, Amato J. Giaccia, James D. Brooks
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (7): 1346–1358.
https://doi.org/10.1158/1078-0432.CCR-24-3028
Published: 01 April 2025
View article titled, Targeting AXL Inhibits the Growth and Metastasis of Prostate Cancer in Bone
Open the PDF for Targeting AXL Inhibits the Growth and Metastasis of Prostate Cancer in Bone in another window
Includes: Supplementary data
Journal Articles

Framework for the Pathology Workup of Metastatic Castration-Resistant Prostate Cancer Biopsies

Available to Purchase
Michael C. Haffner, Michael J. Morris, Chien-Kuang C. Ding, Erolcan Sayar, Rohit Mehra, Brian Robinson, Lawrence D. True, Martin Gleave, Tamara L. Lotan, Rahul Aggarwal, Jiaoti Huang, Massimo Loda, Peter S. Nelson, Mark A. Rubin, Himisha Beltran
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (3): 466–478.
https://doi.org/10.1158/1078-0432.CCR-24-2061
Published: 03 February 2025
View article titled, Framework for the Pathology Workup of Metastatic Castration-Resistant Prostate Cancer Biopsies
Open the PDF for Framework for the Pathology Workup of Metastatic Castration-Resistant Prostate Cancer Biopsies in another window
Includes: Supplementary data
Journal Articles

Correction: Alternative Splicing of EZH2 pre-mRNA by SF3B3 Contributes to the Tumorigenic Potential of Renal Cancer

Free
Ke Chen, Haibing Xiao, Jin Zeng, Gan Yu, Hui Zhou, Chunhua Huang, Weimin Yao, Wei Xiao, Junhui Hu, Wei Guan, Lily Wu, Jiaoti Huang, Qihong Huang, Hua Xu, Zhangqun Ye
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (8): 1736.
https://doi.org/10.1158/1078-0432.CCR-22-0563
Published: 14 April 2022
View article titled, Correction: Alternative Splicing of EZH2 pre-mRNA by SF3B3 Contributes to the Tumorigenic Potential of Renal Cancer
Open the PDF for Correction: Alternative Splicing of EZH2 pre-mRNA by SF3B3 Contributes to the Tumorigenic Potential of Renal Cancer in another window
Includes: Supplementary data
Journal Articles

Pathology: Hub and Integrator of Modern, Multidisciplinary [Precision] Oncology

Available to Purchase
The AACR Pathology Task Force, Carolyn C. Compton, Angelo M. De Marzo, Jayanta Debnath, Keith D. Eaton, Kojo Elenitoba-Johnson, Michelangelo Fiorentino, Christopher A. French, Thomas J. Fuchs, Felice Giangaspero, Jiaoti Huang, A. John Iafrate, Michael M. Ittmann, Roy A. Jensen, Annette S. Kim, Massimo Loda, Robin G. Lorenz, Tamara L. Lotan, Anirban Maitra, Gerrit A. Meijer, Richard N. Mitchell, Anil V. Parwani, Francesco Pezzella, Eli Pikarsky, Jorge S. Reis-Filho, Andrea L. Richardson, Mark A. Rubin, Lawrence D. True
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (2): 265–270.
https://doi.org/10.1158/1078-0432.CCR-21-1206
Published: 19 January 2022
View article titled, Pathology: Hub and Integrator of Modern, Multidisciplinary [Precision] Oncology
Open the PDF for Pathology: Hub and Integrator of Modern, Multidisciplinary [Precision] Oncology in another window
Journal Articles

Copy Number Loss of 17q22 Is Associated with Enzalutamide Resistance and Poor Prognosis in Metastatic Castration-Resistant Prostate Cancer

Free
Xiangnan Guan, Duanchen Sun, Eric Lu, Joshua A. Urrutia, Robert Evan Reiter, Matthew Rettig, Christopher P. Evans, Primo Lara, Jr, Martin Gleave, Tomasz M. Beer, George V. Thomas, Jiaoti Huang, Rahul R. Aggarwal, David A. Quigley, Adam Foye, William S. Chen, Jack Youngren, Alana S. Weinstein, Joshua M. Stuart, Felix Y. Feng, Eric J. Small, Zheng Xia, Joshi J. Alumkal
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (17): 4616–4624.
https://doi.org/10.1158/1078-0432.CCR-19-2303
Published: 01 September 2020
View article titled, Copy Number Loss of 17q22 Is Associated with Enzalutamide Resistance and Poor Prognosis in Metastatic Castration-Resistant Prostate Cancer
Open the PDF for Copy Number Loss of 17q22 Is Associated with Enzalutamide Resistance and Poor Prognosis in Metastatic Castration-Resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Leukemia Inhibitory Factor Promotes Castration-resistant Prostate Cancer and Neuroendocrine Differentiation by Activated ZBTB46

Free
Yen-Nien Liu, Shaoxi Niu, Wei-Yu Chen, Qingfu Zhang, Yulei Tao, Wei-Hao Chen, Kuo-Ching Jiang, Xufeng Chen, Huaiyin Shi, Aijun Liu, Jinhang Li, Yanjing Li, Yi-Chao Lee, Xu Zhang, Jiaoti Huang
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (13): 4128–4140.
https://doi.org/10.1158/1078-0432.CCR-18-3239
Published: 01 July 2019
View article titled, Leukemia Inhibitory Factor Promotes Castration-resistant Prostate Cancer and Neuroendocrine Differentiation by Activated ZBTB46
Open the PDF for Leukemia Inhibitory Factor Promotes Castration-resistant Prostate Cancer and Neuroendocrine Differentiation by Activated ZBTB46 in another window
Includes: Supplementary data
Journal Articles

Alternative Splicing of EZH2 pre-mRNA by SF3B3 Contributes to the Tumorigenic Potential of Renal Cancer

Free
Ke Chen, Haibing Xiao, Jin Zeng, Gan Yu, Hui Zhou, Chunhua Huang, Weimin Yao, Wei Xiao, Junhui Hu, Wei Guan, Lily Wu, Jiaoti Huang, Qihong Huang, Hua Xu, Zhangqun Ye
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (13): 3428–3441.
https://doi.org/10.1158/1078-0432.CCR-16-2020
Published: 01 July 2017
View article titled, Alternative Splicing of EZH2 pre-mRNA by SF3B3 Contributes to the Tumorigenic Potential of Renal Cancer
Open the PDF for Alternative Splicing of EZH2 pre-mRNA by SF3B3 Contributes to the Tumorigenic Potential of Renal Cancer in another window
Includes: Supplementary data
Journal Articles

Molecular Profiling to Determine Clonality of Serial Magnetic Resonance Imaging/Ultrasound Fusion Biopsies from Men on Active Surveillance for Low-Risk Prostate Cancer

Free
Ganesh S. Palapattu, Simpa S. Salami, Andi K. Cani, Daniel H. Hovelson, Lorena Lazo de la Vega, Kelly R. Vandenberg, Jarred V. Bratley, Chia-Jen Liu, Lakshmi P. Kunju, Jeffery S. Montgomery, Todd M. Morgan, Shyam Natarajan, Jiaoti Huang, Scott A. Tomlins, Leonard S. Marks
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (4): 985–991.
https://doi.org/10.1158/1078-0432.CCR-16-1454
Published: 14 February 2017
View article titled, Molecular Profiling to Determine Clonality of Serial Magnetic Resonance Imaging/Ultrasound Fusion Biopsies from Men on Active Surveillance for Low-Risk Prostate Cancer
Open the PDF for Molecular Profiling to Determine Clonality of Serial Magnetic Resonance Imaging/Ultrasound Fusion Biopsies from Men on Active Surveillance for Low-Risk Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Molecular Signature to Risk-Stratify Prostate Cancer of Intermediate Risk

Free
Yu Yin, Qingfu Zhang, Hong Zhang, Yiping He, Jiaoti Huang
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2017) 23 (1): 6–8.
https://doi.org/10.1158/1078-0432.CCR-16-2400
Published: 02 January 2017
View article titled, Molecular Signature to Risk-Stratify Prostate Cancer of Intermediate Risk
Open the PDF for Molecular Signature to Risk-Stratify Prostate Cancer of Intermediate Risk in another window
Journal Articles

Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance

Free
Hanwei Zhang, Kris Prado, Kelvin X. Zhang, Elizabeth M. Peek, Jane Lee, Xiaoyan Wang, Jiaoti Huang, Gang Li, Matteo Pellegrini, Arnold I. Chin
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (21): 5349–5361.
https://doi.org/10.1158/1078-0432.CCR-15-2581
Published: 31 October 2016
View article titled, Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance
Open the PDF for Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance in another window
Includes: Supplementary data
Journal Articles

Aggressive Variants of Castration-Resistant Prostate Cancer

Free
Himisha Beltran, Scott Tomlins, Ana Aparicio, Vivek Arora, David Rickman, Gustavo Ayala, Jiaoti Huang, Lawrence True, Martin E. Gleave, Howard Soule, Christopher Logothetis, Mark A. Rubin
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (11): 2846–2850.
https://doi.org/10.1158/1078-0432.CCR-13-3309
Published: 29 May 2014
View article titled, Aggressive Variants of Castration-Resistant Prostate Cancer
Open the PDF for Aggressive Variants of Castration-Resistant Prostate Cancer in another window
Journal Articles

CXCR2 Promotes Ovarian Cancer Growth through Dysregulated Cell Cycle, Diminished Apoptosis, and Enhanced Angiogenesis

Free
Gong Yang, Daniel G. Rosen, Guangzhi Liu, Fan Yang, Xiaoqing Guo, Xue Xiao, Fengxia Xue, Imelda Mercado-Uribe, Jiaoti Huang, Sue-Hwa Lin, Gordon B. Mills, Jinsong Liu
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (15): 3875–3886.
https://doi.org/10.1158/1078-0432.CCR-10-0483
Published: 28 July 2010
View article titled, CXCR2 Promotes Ovarian Cancer Growth through Dysregulated Cell Cycle, Diminished Apoptosis, and Enhanced Angiogenesis
Open the PDF for CXCR2 Promotes Ovarian Cancer Growth through Dysregulated Cell Cycle, Diminished Apoptosis, and Enhanced Angiogenesis in another window
Includes: Supplementary data